Advanced search
Start date
Betweenand

Osteochondral lesions treatment with parylene

Grant number: 15/08952-6
Support type:Scholarships abroad - Research
Effective date (Start): August 01, 2015
Effective date (End): July 31, 2016
Field of knowledge:Health Sciences - Medicine - Surgery
Principal researcher:CARLOS EDUARDO DA SILVEIRA FRANCIOZI
Grantee:CARLOS EDUARDO DA SILVEIRA FRANCIOZI
Host: James Eugene Tibone
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Research place: University of Southern California (USC), United States  

Abstract

Cartilage lesions have a low potential for healing due to its avascular nature and hypocellularity. Consequently, they tend to become symptomatic and progress with joint degeneration leading ultimately to the development of arthrosis. Despite the many existing surgical treatments for chondral lesions, there is no gold standard. Results worse along time and the formation of fibrocartilage, instead normal articular cartilage, leads to degeneration since it has inferior biomechanical properties. Since the second-generation autologous chondrocyte transplantation, the development of scaffolds for the treatment of chondral and osteochondral lesions underwent rapid growth gaining importance and popularity represented by the emergence of a myriad of materials and techniques. Scaffold based regenerative procedures are interesting because the scaffold provides a three-dimensional structure that mimics the organizational structure of the cartilage allowing the growth of living cells. The parylene-C is a biocompatible polymer approved for chronic implantation in the human body. With submicron thickness, obtained through a specific production process, it was demonstrated that this membrane allows diffusion of nutrients and macromolecules. This polymer appears to be a good option for the treatment of chondral injuries. Sixty knees of 30 rabbits will be operated. There will be four treatment groups: Group N - control with spontaneous repair. Group P - parylene scaffold. Group CP - parylene scaffold and minced autologous cartilage. Group C - minced autologous cartilage. The results will be histologically evaluated analyzing the biocompatibility, the presence of debris, tosteochondral scaffold integration, the quality of the repair tissue by O'Driscoll scale and the effect of parylene at the opposing cartilage. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DE CARVALHO, ROGERIO TEIXEIRA; FRANCIOZI, CARLOS EDUARDO; ITAMI, YASUO; MCGARRY, MICHELLE H.; MCNEILL INGHAM, SHEILA JEAN; ABDALLA, RENE JORGE; TIBONE, JAMES EUGENE; LEE, THAY Q.. Bicruciate lesion biomechanics, Part 1-Diagnosis: translations over 15 mm at 90 degrees of knee flexion are indicative of a complete tear. KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, v. 27, n. 9, p. 2927-2935, . (15/10317-7, 15/08952-6)
FRANCIOZI, CARLOS EDUARDO; DE CARVALHO, ROGERIO TEIXEIRA; ITAMI, YASUO; MCGARRY, MICHELLE H.; MCNEILL INGHAM, SHEILA JEAN; ABDALLA, RENE JORGE; TIBONE, JAMES EUGENE; LEE, THAY Q.. Bicruciate lesion biomechanics, Part 2-treatment using a simultaneous tensioning protocol: ACL fixation first is better than PCL fixation first to restore tibiofemoral orientation. KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, v. 27, n. 9, p. 2936-2944, . (15/10317-7, 15/08952-6)
DA SILVEIRA FRANCIOZI, CARLOS EDUARDO; VANGSNESS, JR., CARLETON THOMAS; MARTINEZ, JUAN CARLOS; RODGER, DAMIEN; CHOU, TZU-CHIEH; TAI, YU-CHONG; BRANT, RODRIGO; WU, LING; ABDALLA, RENE JORGE; HAN, BO; et al. Parylene scaffold for cartilage lesion. BIOMEDICAL MICRODEVICES, v. 19, n. 2, . (15/08952-6)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.